W. Ruka

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Piotr Rutkowski, M. van Glabbeke, Cathryn Rankin et al. · Journal of Clinical Oncology · 2010 · 398 citations · Full text

Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience

Natale Cascinelli, Filiberto Belli, Mario Santinami et al. · Annals of Surgical Oncology · 2000 · 332 citations

Dermoscopic Image, Surgical Pathology, Melanoma +5

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Alexander M.M. Eggermont, Stefan Suciu, Rona M. MacKie et al. · The Lancet · 2005 · 310 citations

Surgical Oncology, Oncology, Melanoma +7

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

Piotr Rutkowski, Zbigniew Nowecki, Wanda Michej et al. · Annals of Surgical Oncology · 2007 · 265 citations · Full text

Prognostic Factors, Surgical Oncology, Gastrointestinal Oncology +13

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

V. Bramwell, Jacques Rouëssé, William P. Steward et al. · Journal of Clinical Oncology · 1994 · 249 citations